First Affirmative Financial Network Sells 475 Shares of Colgate-Palmolive (NYSE:CL)

First Affirmative Financial Network lowered its stake in Colgate-Palmolive (NYSE:CL) by 13.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,055 shares of the company’s stock after selling 475 shares during the period. First Affirmative Financial Network’s holdings in Colgate-Palmolive were worth $278,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Peak Financial Advisors LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at $1,315,000. Gordian Advisors LLC acquired a new stake in Colgate-Palmolive in the third quarter worth $602,000. Carrera Capital Advisors grew its holdings in Colgate-Palmolive by 23.1% in the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after purchasing an additional 7,353 shares during the period. Fiduciary Alliance LLC acquired a new stake in Colgate-Palmolive in the fourth quarter worth $4,066,000. Finally, Vontobel Holding Ltd. grew its holdings in Colgate-Palmolive by 224.6% in the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock worth $82,626,000 after purchasing an additional 550,750 shares during the period. Institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on CL shares. Barclays reduced their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. TD Cowen lowered their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Wells Fargo & Company lowered their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. UBS Group lowered their price objective on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research report on Thursday, January 16th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research report on Thursday, January 16th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Hold” and an average target price of $102.00.

Colgate-Palmolive Price Performance

CL stock opened at $90.96 on Friday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a one year low of $82.68 and a one year high of $109.30. The stock has a market cap of $74.31 billion, a PE ratio of 26.06, a P/E/G ratio of 3.59 and a beta of 0.44. The firm has a 50 day simple moving average of $91.58 and a two-hundred day simple moving average of $97.29.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.20%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.